drugset / Trial / NCT06111872

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

NCT06111872

Phase 2 Completed 90 enrolled National University of Malaysia
RandomizedParallel-groupSingle-blindTreatment

Summary

Does Ketamine-Midazolam have a better efficacy and safety profile compared to Midazolam - Pethidine in Endoscopic Retrograde Cholangiopancreatography (ERCP)?

Timeline

Start
2023-07-18
Primary completion
2024-02-27
Completion
2024-10-25

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous
Subject Midazolam Small molecule 0.02 mg/kg Intravenous
Subject Midazolam Small molecule 0.05 mg/kg Intravenous
Comparator Pethidin Unknown 0.7 ug/kg Intravenous